The therapeutic potential of psychedelic drugs: past, present and future

Plant-based psychedelics such as psilocybin have an ancient history of medicinal use. After the first English-language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aides to psychotherapy for the treatment of mood disorder...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Carhart-Harris, R, Goodwin, G
स्वरूप: Journal article
प्रकाशित: Springer Nature 2017
_version_ 1826303936328368128
author Carhart-Harris, R
Goodwin, G
author_facet Carhart-Harris, R
Goodwin, G
author_sort Carhart-Harris, R
collection OXFORD
description Plant-based psychedelics such as psilocybin have an ancient history of medicinal use. After the first English-language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aides to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before prohibitive legislature in the mid-1960s effectively ended all major psychedelic research programmes. Since the early 1990s, there has been a steady revival of human psychedelic research: last year saw reports on the first modern brain imaging study with LSD and 3 separate clinical trials of psilocybin for depressive symptoms. In this Circumspective piece, Robin Carhart-Harris and Guy Goodwin share their opinions on the promises and pitfalls of renewed psychedelic research, with a focus on the development of psilocybin as a treatment for depression.
first_indexed 2024-03-07T06:10:15Z
format Journal article
id oxford-uuid:ef3a841f-2fba-4c50-a17b-6fe6af2bc609
institution University of Oxford
last_indexed 2024-03-07T06:10:15Z
publishDate 2017
publisher Springer Nature
record_format dspace
spelling oxford-uuid:ef3a841f-2fba-4c50-a17b-6fe6af2bc6092022-03-27T11:38:49ZThe therapeutic potential of psychedelic drugs: past, present and futureJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef3a841f-2fba-4c50-a17b-6fe6af2bc609Symplectic Elements at OxfordSpringer Nature2017Carhart-Harris, RGoodwin, GPlant-based psychedelics such as psilocybin have an ancient history of medicinal use. After the first English-language report on LSD in 1950, psychedelics enjoyed a short-lived relationship with psychology and psychiatry. Used most notably as aides to psychotherapy for the treatment of mood disorders and alcohol dependence, drugs such as LSD showed initial therapeutic promise before prohibitive legislature in the mid-1960s effectively ended all major psychedelic research programmes. Since the early 1990s, there has been a steady revival of human psychedelic research: last year saw reports on the first modern brain imaging study with LSD and 3 separate clinical trials of psilocybin for depressive symptoms. In this Circumspective piece, Robin Carhart-Harris and Guy Goodwin share their opinions on the promises and pitfalls of renewed psychedelic research, with a focus on the development of psilocybin as a treatment for depression.
spellingShingle Carhart-Harris, R
Goodwin, G
The therapeutic potential of psychedelic drugs: past, present and future
title The therapeutic potential of psychedelic drugs: past, present and future
title_full The therapeutic potential of psychedelic drugs: past, present and future
title_fullStr The therapeutic potential of psychedelic drugs: past, present and future
title_full_unstemmed The therapeutic potential of psychedelic drugs: past, present and future
title_short The therapeutic potential of psychedelic drugs: past, present and future
title_sort therapeutic potential of psychedelic drugs past present and future
work_keys_str_mv AT carhartharrisr thetherapeuticpotentialofpsychedelicdrugspastpresentandfuture
AT goodwing thetherapeuticpotentialofpsychedelicdrugspastpresentandfuture
AT carhartharrisr therapeuticpotentialofpsychedelicdrugspastpresentandfuture
AT goodwing therapeuticpotentialofpsychedelicdrugspastpresentandfuture